Exosens
EXENS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €394,100 | €318,796 | €200,751 | €166,168 |
| % Growth | 23.6% | 58.8% | 20.8% | – |
| Cost of Goods Sold | €168,500 | €141,987 | €86,799 | €66,134 |
| Gross Profit | €225,600 | €176,809 | €113,952 | €100,034 |
| % Margin | 57.2% | 55.5% | 56.8% | 60.2% |
| R&D Expenses | €0 | €9,100 | €3,500 | €6,342 |
| G&A Expenses | €112,511 | €82,857 | €63,154 | €56,983 |
| SG&A Expenses | €114,535 | €84,505 | €64,627 | €57,738 |
| Sales & Mktg Exp. | €2,024 | €1,648 | €1,473 | €755 |
| Other Operating Expenses | €34,165 | €27,919 | -€46,960 | €3,999 |
| Operating Expenses | €148,700 | €121,524 | €21,167 | €68,079 |
| Operating Income | €76,900 | €55,285 | €30,450 | €31,955 |
| % Margin | 19.5% | 17.3% | 15.2% | 19.2% |
| Other Income/Exp. Net | -€35,100 | -€36,347 | -€13,346 | -€182,220 |
| Pre-Tax Income | €41,800 | €18,938 | €17,104 | -€150,265 |
| Tax Expense | €11,100 | €1,798 | €5,893 | -€1,299 |
| Net Income | €30,700 | €17,140 | €11,212 | -€148,965 |
| % Margin | 7.8% | 5.4% | 5.6% | -89.6% |
| EPS | 0.6 | 0.56 | 0.37 | -4.9 |
| % Growth | 7.1% | 51.4% | 107.6% | – |
| EPS Diluted | 0.6 | 0.56 | 0.37 | -4.9 |
| Weighted Avg Shares Out | 50,783 | 30,387 | 30,387 | 30,387 |
| Weighted Avg Shares Out Dil | 50,783 | 30,387 | 30,387 | 30,387 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €537 | €0 | €0 |
| Interest Expense | €27,839 | €30,784 | €15,154 | €37,599 |
| Depreciation & Amortization | €38,200 | €34,187 | €18,989 | €11,488 |
| EBITDA | €115,200 | €83,909 | €51,247 | -€101,178 |
| % Margin | 29.2% | 26.3% | 25.5% | -60.9% |